Hoese & Co’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.1K Hold
285
0.02% 137
2026
Q1
$24.3K Hold
285
0.02% 109
2025
Q4
$22.5K Hold
285
0.02% 113
2025
Q3
$22.8K Hold
285
0.02% 102
2025
Q2
$25.9K Hold
285
0.02% 119
2025
Q1
$26.7K Hold
285
0.02% 94
2024
Q4
$25.9K Hold
285
0.02% 99
2024
Q3
$29.6K Hold
285
0.02% 87
2024
Q2
$26.5K Hold
285
0.02% 80
2024
Q1
$24.7K Hold
285
0.02% 84
2023
Q4
$22.4K Hold
285
0.02% 91
2023
Q3
$20.3K Hold
285
0.02% 96
2023
Q2
$22K Hold
285
0.02% 101
2023
Q1
$20.9K Hold
285
0.02% 97
2022
Q4
$22K Hold
285
0.02% 101
2022
Q3
$20K Hold
285
0.02% 102
2022
Q2
$23K Hold
285
0.03% 100
2022
Q1
$22K Buy
+285
New +$22.6K 0.02% 110

Other funds holding CL

Hoese & Co's CL Position: Q2 2026 in Review

Hoese & Co held its Colgate-Palmolive (CL) position steady in Q2 2026 at 285 shares worth $26.1K. The position accounts for 0.02% of the portfolio, ranked #137.

Hoese & Co first reported a position in CL in Q1 2022 and has held it in 18 quarters since. The position peaked at $29.6K in Q3 2024. 597 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Hoese & Co held 285 shares of Colgate-Palmolive worth $26.1K as of Q2 2026.
  • Hoese & Co left its Colgate-Palmolive share count unchanged in Q2 2026.
  • Colgate-Palmolive made up 0.02% of Hoese & Co's portfolio in Q2 2026, its #137 holding.
  • Hoese & Co first reported a position in Colgate-Palmolive in Q1 2022 and has held it in 18 quarters since.
  • Hoese & Co's Colgate-Palmolive position peaked at $29.6K in Q3 2024.
  • 597 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Hoese & Co's 13F filing for Q2 2026, filed 14 Jul 2026.